ENOV (Enovis) Issuance of Debt: $544 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ENOV Enovis Corp ENOV
66 GF Score
Price $29.30
GF Value $50.24
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Enovis Issuance of Debt?

Enovis ENOV -3.17% 66 Issuance of Debt is $544 Mil as of Mar. 2026. GuruFocus rates ENOV with a GF Score™ of 66/100 and a GF Value™ of $50.24 (Possible Value Trap). The stock has 9 warning signs investors should review.

Enovis's Issuance of Debt for the three months ended in Mar. 2026 was $72 Mil.

Enovis's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $544 Mil.

Enovis Issuance of Debt Related Terms

Enovis Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Enovis's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovis Issuance of Debt Chart

Enovis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 991.49 515.00 915.00 1,392.00 544.00

Enovis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.00 55.00 50.00 367.00 72.00
ENOV
66GF Score
Enovis Corp ENOV
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enovis Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $544 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $544 Mil mean?
Enovis (ENOV) has a Issuance of Debt of $544 Mil as of Mar. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Enovis and its competitors.
Is Enovis' Issuance of Debt too high?
Enovis' current Issuance of Debt is $544 Mil. Overall, Enovis has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enovis' Issuance of Debt compare to IART and AHCO?
Enovis' Issuance of Debt of $544 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Medical Devices & Instruments company?
A good Issuance of Debt depends on the Medical Devices & Instruments industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Enovis and its competitors. Enovis's current Issuance of Debt is $544 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enovis stock overvalued right now?
Based on GuruFocus' analysis, Enovis (ENOV) is currently considered Possible Value Trap. The stock's GF Value™ is $50.24, compared to a current price of $29.30 — trading 41.7% below its estimated fair value. The current Issuance of Debt is $544 Mil. Enovis' overall GF Score™ is 66/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Enovis (ENOV), the current Issuance of Debt is $544 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $29.30 is trading 41.7% below its estimated GF Value™ of $50.24. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Issuance of Debt: $544 Mil
  • GF Value™: $50.24 vs. price of $29.30 (41.7% below fair value)
  • GF Score™: 66/100 with 9 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
66GF Score

Get the complete analysis for ENOV

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.30
Price
$50.24
GF Value